HC Andersen Capital Events 22.09.22: Meet the top management in InDex Pharmaceuticals
HC Andersen Capital are hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.InDex Pharmaceuticals - Positive feedback form Japanese authorities (PDMA) for CobitolimodMeet and ask questions to Acting CEO Johan Gileus from InDex Pharmaceuticals and CMO Anders Bröjersen who will update us on the announcement regarding Cobitolimod in Japan.The phase 3 program – Conclude, consists of two sequential global induction studies and a year-long maintenance study. The first phase 3 study of Conclude is ongoing and results are